News | May 07, 2021
Lonza announces expansion plans for mammalian manufacturing facilities
The facility is expected to be completed in 2024
The facility is expected to be completed in 2024
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
DHL and other logistics companies were already transporting pharmaceutical products at minus 70°C in Schaumaplast boxes packed with dry ice before the coronavirus pandemic
Subscribe To Our Newsletter & Stay Updated
